The transition of TGF-β from a protective role early in tumor development to a tumor-promoting one in more advanced disease appears to be a watershed moment in many cancers, reflecting global derangement of signal transduction through genetic and epigenetic mechanisms. The gene discussed is TGFB1; the disease is neoplasm.